Biomedical subjects
Publications and source records attributed to J Hollman.
Analyzing data of PTCA performed at our institution on people above age 65, we have been encouraged by its safety and the initially favorable angiographic and hemodynamic result. Projecting from Jang et al's data regarding relative cost effectiveness of PTCA and coronary bypass surgery at various major medical centers, PTCA was less costly by a factor of 2 to 5. This cost differential may actually be higher in the elderly.
In summary, coronary angioplasty has proved to be an alternative to bypass surgery in relieving angina in selected patients. Unfortunately, some patients experience early transient chest pain during their hospitalization. Early prolonged chest pain with electrocardiographic changes requires nursing attention because it may represent an acute complication of PTCA requiring immediate medical intervention.
To assess the risk of side branch occlusion during percutaneous transluminal coronary angioplasty (PTCA), 600 consecutive procedures were analyzed. On the basis of pre-PTCA angiograms of 557 patients in whom the balloon was actually inflated, 365 side branches in 302 patients (54% of patients) were deemed in jeopardy. A total of 122 side branches in 102 patients (18%) originated from the lesion segment itself, i.e., their take-off was narrowed (Group I, 33% of side branches at risk), whereas 243 side branches in 214 patients (38%) originated from the immediate vicinity of the stenosis in a way that they were subjected to temporary occlusion during balloon dilatation (Group II, 67% of side branches at risk). Patency of side branches was determined by consensus of 2 observers. Criteria for occlusion were disappearance, filling by collaterals, or stagnation of flow. After PTCA, 20 of 365 side branches (5%) were occluded and associated with chest pain in 5 patients, creatine kinase increase in 6, left anterior hemiblock, septal Q waves and transient atrial fibrillation in 1 and non-sustained ventricular tachycardia in 1 of the 20 patients. Exercise tolerance did not decrease. No local predilection for side branch occlusion was evident. Seventeen of 122 side branches (14%) occluded in Group I, compared with 3 of 243 (1%) in Group II (p less than 0.001). Thus, more than half of the patients who underwent PTCA had side branches at risk for iatrogenic occlusion.(ABSTRACT TRUNCATED AT 250 WORDS)
The advent of improved balloon catheters for percutaneous transluminal coronary angioplasty (PTCA) in 1981 extended the theoretic pressure range available for dilatation from 7 atm to 13 atm. The impact of higher dilatation pressure on results of PTCA was studied. The last 100 consecutive patients treated exclusively with the old balloon type (low-pressure group) were compared to the first 100 consecutive patients treated exclusively with the new balloon type (high-pressure group). There was no difference in age, sex, artery distribution, initial degree of stenosis, and initial pressure gradient between the two groups. The mean peak pressure applied was 7.0 +/- 1.6 atm in the low-pressure group and 8.5 +/- 2.1 atm in the high-pressure group (p less than 0.001). The average balloon diameter used and the number and duration of balloon fillings were similar in both groups. Primary success, complications, and residual degree of stenosis were not different in the two groups. The residual pressure gradient, however, was significantly lower in the high-pressure group (11 +/- 7 mm Hg) than in the low-pressure group (16 +/- 10 mm Hg) (p less than 0.01). This indicates a better immediate hemodynamic result without increased risk. It is concluded that it is safe to perform PTCA with the new balloon types allowing for higher pressures. The increment in average pressure used for dilatation, which occurred incidentally, improved the average hemodynamic outcome. This may influence recurrence rate and deserves further investigation by randomized trials.
The potential of repeat percutaneous transluminal coronary angioplasty as a mode of therapy for recurrence of stenosis after initially successful angioplasty was examined on the basis of data on all 514 patients with successful angioplasty at Emory University before April 1982. Recurrence was found in 171 (33%) of the 514 patients. Repeat angioplasty was attempted in 95 patients with a significantly higher primary success rate (97 versus 85%, p less than 0.001) and a lower complication rate (8 versus 15%, p less than 0.10) than those of initial angioplasty. Follow-up documentation was available in all 92 patients with successful repeat angioplasty. A second recurrence of stenosis was found in 26% (24 of 92). A third angioplasty was performed in seven patients; six procedures were successful and there have been no recurrences of stenosis. Repeat coronary angioplasty provides a means to treat recurrence of stenosis. It proved to be very successful and safe and yielded good long-term results. It also increased the percent of patients with documented lasting success after angioplasty from 63 to 78%.
Until recently, coronary bypass surgery was the only method of revascularization therapy available for patients with coronary artery disease. Now, percutaneous transluminal coronary angioplasty (PTCA), introduced in 1977, has been refined to the degree that it offers a better alternative in selected patients. Primary success rates of more than 90% can be achieved, and emergency bypass surgery can be avoided in all but 3% to 10% of patients and Q-wave infarction in all but 1% to 4%. Because of the availability of PTCA, efforts should be made to identify coronary artery disease early, when patients are most likely to qualify for this procedure.
To determine the influence of adjunctive treatment with coumadin or aspirin on recurrence rate after percutaneous transluminal coronary angioplasty (PTCA), 248 patients in whom PTCA was assessed to be a primary success were randomized to either 325 mm aspirin daily or to coumadin treatment sufficient to maintain a prothrombin time 2 to 2.5 times the control value. The follow-up protocol included stress testing and coronary angiographic examinations 3 to 6 months after PTCA. All patients were followed for at least 9 months. Of the 122 patients randomized to coumadin 44 (36%) had recurrent stenoses as opposed to 34/126 (27%) of patients on aspirin, a difference that did not reach statistical significance at the .05 level. However, patients with at least a 6 month history of angina demonstrated a significantly different response to adjunctive treatment in that 19/43 (44%) of coumadin patients as compared with 10/48 (21%) of aspirin patients had recurrent stenoses (p less than .05). Thus, coumadin was not shown to be more effective than aspirin as adjunctive treatment after PTCA, while aspirin was shown to be superior to coumadin in patients with a longer history of angina.
To improve symptomatic status and avoid reoperation, 122 initial and 7 repeat percutaneous transluminal coronary angioplasty procedures were performed in 116 patients with disabling angina pectoris at a mean of 26.8 months (range 2 to 132) after coronary bypass surgery. Marked angiographic improvement (greater than 30% reduction in diameter stenosis) was obtained in 107 (88%) of the 122 initial procedures and in all 7 repetitions. Mean stenosis was reduced from 78 +/- 13% (mean +/- standard deviation) to 25 +/- 13% (p less than 0.0001) and mean pressure gradient from 49 +/- 15 to 11 +/- 8 mm Hg (p less than 0.0001). Complications were: emergency surgery (three patients), Q wave infarction (one patient), myocardial infarction by enzyme criteria only (four patients) and non-occluding coronary dissection (one patient). There were no neurologic or peripheral vascular complications and no early deaths. One late death occurred 14 months after an unsuccessful but uncomplicated angioplasty procedure. At a mean follow-up of 8.3 months, 88 patients (76%) were free of angina or in improved condition. In patients followed up for at least 6 months, evidence of restenosis occurred in 9 (53%) of 17 saphenous veins, 1 (50%) of 2 proximal graft anastomoses, 4 (18%) of 22 distal graft anastomoses and 5 (14%) of 37 native coronary arteries. When coronary anatomy is suitable, percutaneous transluminal angioplasty is an attractive alternative to reoperation in symptomatic patients with prior coronary bypass surgery.
The clinical course of five patients manifesting coronary artery spasm at the site of previous successful percutaneous coronary angioplasty is reviewed. All patients showed this spasm on hemodynamically insignificant (less than 50% diameter narrowing) obstruction. Four patients did not respond to therapy with calcium channel antagonists and nitrates and subsequently developed recurrent stenosis. One patient died 2 months after angioplasty and 1 day after coronary bypass surgery. Pathologic study at the site of angioplasty revealed new artherosclerotic disease. Coronary spasm may occur during the healing period after coronary angioplasty and should be distinguished from fixed obstruction.
In 526 patients undergoing a first percutaneous transluminal coronary angioplasty (PTCA) of a single native vessel, we studied the influence of length and eccentricity of the lesion on complications and primary success. Long stenoses (greater than or equal to 5 mm, n = 153) did not differ from short stenoses (less than or equal to 4 mm, n = 265) in terms of overall complications or gain in lumen diameter and distal pressure. Eccentric stenoses (n = 155) showed a lower rate of primary success than concentric stenoses (n = 338) (80% vs 89%, p less than 0.05). Inability to cross the stenosis was the main reason for failure. Stenoses that were long and eccentric (n = 51) had the highest incidence of complications (24%) and stenoses that were short and concentric (n = 177) the lowest (12%, p less than 0.05). However, the average outcome expressed by gain in lumen diameter and distal pressure was equal in both groups and is obviously more dependent on technical factors than on anatomy. Nevertheless, length and, particularly, eccentricity of a lesion constitute risk factors for PTCA. They may be overcome by technical skill and sophisticated equipment, such as steerable catheters.
We evaluated all patients receiving percutaneous transluminal coronary angioplasty (PTCA) in the past year for mild stenosis (60% or less diameter narrowing, n = 64, group 1) and compared them with a random sample of 330 patients with greater than 60% stenosis (n = 66, group 2) treated during the same year. The degree of coronary stenosis before PTCA was 52 +/- 7% (mean +/- SD) in group 1 and 79 +/- 11% in group 2. The primary success rate was 90% (58 of 64 patients) in group 1 vs 86% (57 of 66 patients) in group 2. The incidence of complications requiring coronary surgery after PTCA failed was similar in both groups (3 of 64 in group 1, 4 of 66 in group 2), but there were four occurrences of myocardial infarction in group 1 and none in group 2 (p less than .05). Recurrence of stenosis was judged on the basis of objective data, 76% of which were angiographic data, in 97% of the patients with primary success. At a mean interval of 5 months with a mean follow-up period of 7 months, 17 of 58 patients (29%) with primary success in group 1 and 24 of 57 patients (42%) in group 2 developed restenosis. In group 1, restenosis was markedly more severe (73 +/- 15%) than initial stenosis (p less than .005), which was not the case in group 2. In conclusion, PTCA in mild stenosis has favorable primary and long-term results, yet carries the risk of myocardial infarction and emergency operation and may, in some cases, even accelerate the disease process.
Between July 1980 and November 1982, there were 935 coronary angioplasties attempted at Emory University Hospital. Of these patients, 20 developed acute occlusion. Of these 20, 19 presented within 3 hr of surgery or within 3 hr after stopping a continuous heparin infusion. Five patients required emergency surgery, but in 15 nitrates, nifedipine, and/or repeat angioplasty reopened the artery and the patient could be stabilized on continuous infusions of heparin and nitroglycerin. In only one case was an occluding thrombus evident on angiographic examination. The mechanism of acute occlusion is unknown, but coronary artery spasm may play a role.
In early reports of percutaneous transluminal coronary angioplasty (PTCA) in women, the complication rate was higher and the success rate lower than in men. From December, 1980, to December, 1986, 969 women aged 61 (32-84) years and 2,727 men aged 57 (27-84) years underwent PTCA, at our institution. At the time of PTCA 26% of the women had functional class IV angina pectoris compared to 16% of the men (P less than 0.005). Women more often had hypertension (56% vs 39%), left ventricular hypertrophy, diabetes mellitus (19% vs 11%; P less than 0.0005), and family history of coronary artery disease than men. Significantly more of the men (74%) smoked than did the women (53%). The success rate in women was 93% as compared to an angiographic success rate in 2,727 men of 93.5% (ns). The rate of emergency bypass surgery in women was 3.8% as compared to 3.2% in men (ns). The death rate was 0.3% in women as compared to 0.09% in men. Women underwent more PTCA of the left anterior descending coronary artery (52% vs 48% of lesions in men; P less than 0.05) and right coronary artery (32% vs 27% in men; P less than 0.0005). Fewer of the women (9%) had had previous bypass surgery than had the men (15% P less than 0.0005). Procedural details, including balloon diameter, vessel diameter, lesion response pressure, inflation number, and maximum inflation pressures used as PTCA, were not different between men and women. Women had significantly more ST segment shift of 1 mm of more at the time of balloon inflation than men (P less than 0.0005).(ABSTRACT TRUNCATED AT 250 WORDS)
During 1968 consecutive percutaneous transluminal coronary angioplasty (PTCA) procedures, 4 patients (0.2%) suffered a focal central nervous system complication. Two patients had a hemisphere infarct, one a brainstem infarct and one a hemisphere transient ischemic attack. Embolism was the likely mechanism in 3 cases; in 1 air was injected through the guiding catheter, and in 2 post-coronary bypass cases the ascending aorta was "scraped" with the guiding catheter while searching for a graft ostium. In 1 case the event occurred after a successful PTCA during a period of hypotension. Neurologic complications are rare during PTCA but will occasionally occur as the procedure is performed more frequently.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Non-Q-wave infarction is associated with a significant incidence of infarction and death. We followed 52 patients who underwent percutaneous transluminal coronary angioplasty (PTCA) within three months of non-Q-wave myocardial infarction. Thirty-eight patients had single-vessel disease, 12 had double-vessel disease, and two had triple-vessel disease. At follow-up at 28 +/- 8 months, all patients were alive. Three suffered a recurrent myocardial infarction during the follow-up period. Nine underwent repeat angioplasty. Four patients had bypass surgery for recurrent symptoms. Only 25% of the patients had angina at follow-up, and all but two were in an improved functional class. PTCA may be used safely in the management of patients after non-Q-wave infarction and results in a favorable long-term prognosis.